Updated weekly. Details via Crossref

Crossref	Scopus	Google Scholar
5	4	Search

2025	Monocyte-related markers as predictors of immune checkpoint inhibitor efficacy and immune-related adverse events: a systematic review and meta-analysis Cancer and Metastasis Reviews Aiarpi Ezdoglian, Michel Tsang-A-Sjoe, Fatemeh Khodadust, George Burchell, Gerrit Jansen, Tanja de Gruijl, Mariette Labots, Conny J. van der Laken
2024	Nomogram-based prognostic tool for stage IIIB/IV non-small cell lung cancer patients undergoing traditional Chinese medicine treatment Heliyon Yihong Liu, Haochuan Ma, Rui Zhou, Yadong Chen, Yanjuan Zhu, Xuesong Chang, Jicai Chen, Haibo Zhang
2024	Evaluation of the efficacy of PD‑1/PD‑L1 inhibitor plus bevacizumab and chemotherapy for the treatment of patients with driver gene‑negative advanced‑stage lung adenocarcinoma: A retrospective cohort study Oncology Letters Xiaozun Yang, Xin Li, Ke Huang, Xiang Zhuang
2023	A practical prognostic peripheral blood-based risk model for the evaluation of the likelihood of a response and survival of metastatic cancer patients treated with immune checkpoint inhibitors BMC Cancer Satu Tiainen, Veera Nurmela, Tuomas Selander, Patrik Turunen, Sanna Pasonen-Seppänen, Tiia Kettunen, Outi Kuittinen, Päivi Auvinen, Aino Rönkä
	Additional cited-by details will be shown when available from Crossref